Tivic Health Systems, Inc. (TIVC)
TIVC Stock Price Chart
Explore Tivic Health Systems, Inc. interactive price chart. Choose custom timeframes to analyze TIVC price movements and trends.
TIVC Company Profile
Discover essential business fundamentals and corporate details for Tivic Health Systems, Inc. (TIVC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
11 Nov 2021
Employees
52.00
Website
https://tivichealth.comCEO
Michael Kevin Handley
Description
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.
TIVC Financial Timeline
Browse a chronological timeline of Tivic Health Systems, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
EPS estimate is -$408.00, while revenue estimate is $460.00k.
Earnings released on 25 Mar 2026
EPS came in at -$0.90 , while revenue for the quarter reached -$302.00k .
Earnings released on 14 Nov 2025
EPS came in at -$1.97 , while revenue for the quarter reached $146.00k .
Earnings released on 14 Aug 2025
EPS came in at -$2.19 , while revenue for the quarter reached $86.00k .
Earnings released on 15 May 2025
EPS came in at -$2.52 , while revenue for the quarter reached $70.00k .
Earnings released on 21 Mar 2025
EPS came in at -$15.42 surpassing the estimated -$85.00 by +81.86%, while revenue for the quarter reached $180.00k , missing expectations by -87.41%.
Stock split effective on 7 Mar 2025
Shares were split 1 : 17 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$3.91 surpassing the estimated -$102.00 by +96.17%, while revenue for the quarter reached $126.00k , missing expectations by -90.00%.
Earnings released on 14 Aug 2024
EPS came in at -$5.44 surpassing the estimated -$102.00 by +94.67%, while revenue for the quarter reached $140.00k , missing expectations by -87.61%.
Earnings released on 15 May 2024
EPS came in at -$17.18 surpassing the estimated -$119.00 by +85.56%, while revenue for the quarter reached $334.00k , missing expectations by -68.79%.
Earnings released on 29 Mar 2024
EPS came in at $1.54 surpassing the estimated -$1.19 by +229.71%, while revenue for the quarter reached $356.00k , missing expectations by -73.23%.
Earnings released on 14 Nov 2023
EPS came in at -$25.17 surpassing the estimated -$119.05 by +78.86%, while revenue for the quarter reached $282.00k , missing expectations by -63.85%.
Stock split effective on 23 Aug 2023
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2023
EPS came in at -$119.05 surpassing the estimated -$136.05 by +12.50%, while revenue for the quarter reached $161.00k , missing expectations by -74.44%.
Earnings released on 31 Mar 2023
EPS came in at -$391.16 surpassing the estimated -$527.21 by +25.81%, while revenue for the quarter reached $376.00k , missing expectations by -27.69%.
Earnings released on 13 Mar 2023
EPS came in at -$23.30 falling short of the estimated -$0.31 by -7.42k%, while revenue for the quarter reached $408.00k , missing expectations by -33.11%.
Earnings released on 14 Nov 2022
EPS came in at -$459.18 surpassing the estimated -$544.22 by +15.63%, while revenue for the quarter reached $477.00k , missing expectations by -27.73%.
Earnings released on 15 Aug 2022
EPS came in at -$544.22 falling short of the estimated -$408.16 by -33.33%, while revenue for the quarter reached $528.00k , beating expectations by +14.78%.
Earnings released on 16 May 2022
EPS came in at -$391.16 , while revenue for the quarter reached $428.00k .
Earnings released on 31 Mar 2022
EPS came in at -$55.72 , while revenue for the quarter reached $366.00k .
Earnings released on 30 Sept 2021
EPS came in at -$89.99 , while revenue for the quarter reached $277.00k .
TIVC Stock Performance
Access detailed TIVC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
